Stock AnalizMetlife (MET) earnings for the quarter ended September 2026: EPS beats estimates
Metlife reported results for the quarter ended September 2026 on November 4, 2026. Adjusted earnings per share came in at $2.78 against the analysts’ average forecast of $2.77, a beat of 0.4%.
Revenue for the quarter was $20.52 billion, up 18.2% from $17.36 billion in the same quarter a year earlier.
The market’s verdict: the stock fell 0.9% on the first trading day after the report.
The last four quarters
Metlife has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $2.78 | $2.77 | +0.4% | +18% | −0.9% |
| Jun 2026 | $2.43 | $2.29 | +6.2% | +10% | +4.0% |
| Mar 2026 | $2.42 | $2.27 | +6.7% | +3% | −1.4% |
| Dec 2025 | $2.49 | $2.34 | +6.3% | +28% | −2.1% |
What comes next
Analysts expect EPS of $2.63 for the next quarter on average and $10.23 for the fiscal year ending December 31, 2026.
The average analyst price target is $111.12, 8% above the current price of $102.65.
Valuation and score
Metlife scores 2.8 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 13.4, and its intrinsic value under moderate assumptions is about 2% above the current market value. Full Metlife analysis with 10 years of financials
Frequently asked questions
What was Metlife’s EPS for the quarter ended September 2026?
$2.78 adjusted per share, against an analyst consensus of $2.77.
How much revenue did Metlife report?
$20.52 billion, up 18.2% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.